PL1868631T3 - Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej - Google Patents

Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej

Info

Publication number
PL1868631T3
PL1868631T3 PL06724130T PL06724130T PL1868631T3 PL 1868631 T3 PL1868631 T3 PL 1868631T3 PL 06724130 T PL06724130 T PL 06724130T PL 06724130 T PL06724130 T PL 06724130T PL 1868631 T3 PL1868631 T3 PL 1868631T3
Authority
PL
Poland
Prior art keywords
cosmetic
synthesis
preparation
pharmaceutical composition
sirt proteins
Prior art date
Application number
PL06724130T
Other languages
English (en)
Inventor
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Original Assignee
Soc Dextraction Des Principes Actifs Sa Vincience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Dextraction Des Principes Actifs Sa Vincience filed Critical Soc Dextraction Des Principes Actifs Sa Vincience
Publication of PL1868631T3 publication Critical patent/PL1868631T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
PL06724130T 2005-04-01 2006-03-30 Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej PL1868631T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0503202A FR2883752B1 (fr) 2005-04-01 2005-04-01 Utilisation de composes inducteurs de la synthese des proteines sirt dans ou pour la preparation d'une composition cosmetique ou pharmaceutique
EP06724130A EP1868631B1 (en) 2005-04-01 2006-03-30 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition
PCT/EP2006/003190 WO2006103110A1 (en) 2005-04-01 2006-03-30 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition

Publications (1)

Publication Number Publication Date
PL1868631T3 true PL1868631T3 (pl) 2010-10-29

Family

ID=35350233

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06724130T PL1868631T3 (pl) 2005-04-01 2006-03-30 Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej

Country Status (8)

Country Link
US (1) US7842670B2 (pl)
EP (1) EP1868631B1 (pl)
AT (1) ATE473752T1 (pl)
DE (1) DE602006015449D1 (pl)
ES (1) ES2347070T3 (pl)
FR (1) FR2883752B1 (pl)
PL (1) PL1868631T3 (pl)
WO (1) WO2006103110A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900826B1 (fr) * 2006-05-12 2008-08-15 Soc Extraction Principes Actif Utilisation de peptides en tant que principes actifs amincissants.
NZ597055A (en) * 2006-12-15 2012-12-21 Colgate Palmolive Co Liquid hand dish detergent having suspended particulate material
US8193155B2 (en) * 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US8703161B2 (en) * 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
FR2961814B1 (fr) 2010-06-29 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
BR102014014999B1 (pt) * 2014-06-18 2020-12-01 Hypera S.A. combinação para proteção da pele contra danos causados pela radiação infravermelha, composição e uso da combinação

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064411A1 (en) * 2000-12-08 2003-04-03 Herath Herath Mudiyanselage Athula Chandrasiri Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
EP2236131A3 (en) * 2003-07-01 2011-03-02 President and Fellows of Harvard College Sirt1 modulators for manipulating cell/organism lifespan/stress response
EP1844157A4 (en) * 2005-01-25 2009-11-25 Univ Johns Hopkins STRATEGIES FOR THE DESIGN OF SUBSTANCES TO BE TAKEN ON THE SIR2 FAMILY OF ENZYMES

Also Published As

Publication number Publication date
FR2883752A1 (fr) 2006-10-06
ES2347070T3 (es) 2010-10-25
US20090082278A1 (en) 2009-03-26
EP1868631A1 (en) 2007-12-26
DE602006015449D1 (de) 2010-08-26
US7842670B2 (en) 2010-11-30
EP1868631B1 (en) 2010-07-14
ATE473752T1 (de) 2010-07-15
WO2006103110A1 (en) 2006-10-05
FR2883752B1 (fr) 2008-04-11

Similar Documents

Publication Publication Date Title
CL2007002017A1 (es) Compuestos derivados de [4,5']-bipirimidinil-6,4'-diamina; composicion farmaceutica; y uso como inhibidor de la actividad de cinasa en cancer de vejiga, cancer cervical y mieloma multiple.
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
AR047928A1 (es) Derivados de tetrahidropiridoindol
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
BRPI0820471A2 (pt) Derivados de 1,2,3-triazol para uso como inibidores de estearoil-coa dessaturase
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
SE0302546D0 (sv) New compounds
TW200700357A (en) Benzoic acid ester compounds, compositions, uses and methods related thereto
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
ATE437679T1 (de) Wässrige antitranspirant formulierung
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
ATE432710T1 (de) Pharmazeutische zusammensetzungen, die diaminooxidase enthalten
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2007077318A3 (fr) Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
BRPI0511387A (pt) composição e seu uso
FR2881349B1 (fr) Nouvelle utilisation des galactomannanes en tant qu'agent actif en cosmetique.
WO2007003771A3 (fr) Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
FR2915993B1 (fr) Nouveaux ligands agonistes des recepteurs pars, utilisation en medecine humaine ainsi qu'en cosmetique.
EA200700067A1 (ru) Фармацевтическая композиция, содержащая производные пиперазина
ITMI20052515A1 (it) Formulazione farmaceutica per il trattamento della osteoartrite